Summary Australian and New Zealand clinical practice guideline for  the treatment of schizophrenia (2003)

doi:10.1046/j.1039-8562.2003.00535.x

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Systems Maintenance, Monday, 15th February 2010

Wiley InterScience

Australasian Psychiatry

Volume 11 Issue 2, Pages 136 - 147

Published Online: 27 May 2003

2006 Royal Australian and New Zealand College of Psychiatrists

Published on behalf of

Go to Society Site

< Previous Abstract | Next Abstract >

Save Article to My Profile Download Citation Request Permissions

Abstract | References | Full Text: HTML, PDF (Size: 168K) | Related Articles | Citation Tracking

RANZCP CLINICAL PRACTICE GUIDELINES

Summary Australian and New Zealand clinical practice guideline for the treatment of schizophrenia (2003)

Patrick McGorry , Eoin Killackey, Kathryn Elkins, Martin Lambert and Tim Lambert for the RANZCP Clinical Practice Guideline Team for the Treatment of Schizophrenia

Patrick D. McGorry
Professor/Director, Department of Psychiatry, University of Melbourne and ORYGEN Youth Health, Parkville, Vic., Australia.

Eoin Killackey
Clinical Psychologist and Research Fellow, Department of Psychology, University of Melbourne and ORYGEN Research Centre, Parkville, Vic., Australia.

Kathryn Elkins
Research Fellow, ORYGEN Research Centre, Parkville, Vic., Australia.

Martin Lambert
University of Hamburg.

Tim Lambert
Associate Professor, Director, Office for Psychiatric Evaluation and Educational Newmedia, University of Melbourne, Melbourne, Vic., Australia.

Correspondence to Professor Patrick McGorry, ORYGEN Youth Health, 35 Poplar Road, Parkville, Vic. 3052, Australia. Email: mcgorry@ariel.unimelb.edu.au

KEYWORDS

clinical guidelines • evidence-based medicine • schizophrenia

ABSTRACT

Objective: To provide a summary of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Clinical Practice Guideline for the Management of Schizophrenia.

Conclusions: Schizophrenia is a complex and misunderstood illness with a poor public image, but it is more treatable than ever before. A new generation of medication and psychosocial therapies, combined with a first generation of service reform, have created an evidence-based climate of realistic optimism. However, the potential for better outcomes and quality of life for people with schizophrenia has not been translated into reality. The gap between efficacy and effectiveness is wider for schizophrenia than for any other serious medical disorder. These guidelines distil the current evidence and make recommendations based on the best available knowledge. They are based on systematic meta-analyses and comprehensive reviews of the evidence, and their validity is supported by their congruence with several recent rigorous and independent guideline statements from the UK and North America.

DIGITAL OBJECT IDENTIFIER (DOI)

10.1046/j.1039-8562.2003.00535.x About DOI